Comprehensive genomic profiling of primary non-small cell lung carcinoma (NSCLC) has identified mutations of multiple driver genes, especially oncogenes such as AKT1, ALK, EGFR, ERBB2, KRAS, MET, NRAS, BRAF, PIK3CA, RET, ROS1, and others [1, 2]. Here, KRAS is linked to non-small cell lung carcinoma.